Craft

Biomerica

Stock Price

$0.3

2024-10-29

Market Capitalization

$5.2 M

2024-10-29

Revenue

$5.3 M

FY, 2025

Biomerica Summary

Company Summary

Overview
Biomerica manufactures diagnostic tests that are used by hospitals, clinical laboratories, physician’s offices, and consumers around the world. Our testing kits detect medical problems ranging from allergies, ulcers, and cancer to infertility and diabetes.
Type
Public
Status
Active
Founded
1971
HQ
Irvine, CA, US | view all locations
Website
http://www.biomerica.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Mark Sirgo

    Mark Sirgo, Independent Director

    • Zack Irani

      Zack Irani, Chief Executive Officer and Chairman of the Board

      • Cathy Coste

        Cathy Coste, Independent Director

      • Allen Barbieri

        Allen Barbieri, Vice Chairman and Director

      LocationsView all

      1 location detected

      • Irvine, CA HQ

        United States

        17571 Von Karman Ave

      Biomerica Financials

      Summary Financials

      Revenue (Q3, 2026)
      $987.0K
      Gross profit (Q3, 2026)
      ($44.0K)
      Net income (Q3, 2026)
      ($1.3M)
      Cash (Q3, 2026)
      $1.3M
      EBIT (Q3, 2026)
      ($1.3M)
      Enterprise value
      $4.3M

      Footer menu